{
    "name": "dexamethasone intraocular",
    "comment": "Rx",
    "other_names": [
        "Dexycu"
    ],
    "classes": [
        "Corticosteroids",
        "Ophthalmic"
    ],
    "source": "https://reference.medscape.com/drug/dexycu-dexamethasone-intraocular-1000234",
    "pregnancy": {
        "common": [
            "There are no available data regarding use in pregnant women",
            "Topical ocular administration of dexamethasone in mice and rabbits during the period of organogenesis produced cleft palate and embryofetal death in mice and malformations of abdominal wall/intestines and kidneys in rabbits at doses 7 and 5 times higher than the injected recommended human ophthalmic dose, respectively"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Systemically administered corticosteroids are present in human milk and can suppress growth, interfere with endogenous corticosteroid production, or cause other unwanted effects",
            "There is no information regarding the presence of intraocular dexamethasone in human milk, the effects on breastfed infants, or the effects on milk production to inform about risk to an infant during lactation",
            "The development and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for the drug and any potential adverse effects on the breastfed child or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Prolonged use of corticosteroids may result in glaucoma, with damage to the optic nerve and defects in visual acuity and visual fields; use with caution if glaucoma present",
                "Corticosteroids may delay healing after cataract surgery and increase incidence of bleb formation; perforations reported with use of corticosteroids in diseases causing corneal or scleral thinning",
                "May exacerbate infection; not recommended if active viral diseases of the cornea and conjunctiva present (eg, epithelial herpes simplex keratitis, vaccinia, varicella), mycobacterial eye infection, or ocular fungal disease; caution with history of herpes simplex; prolonged use may suppress host response to infection and increases risk of secondary ocular infections",
                "Use in phakic individuals may promote the development of posterior subcapsular cataracts"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Increased intraocular pressure",
            "percent": "5-15"
        },
        {
            "name": "Corneal edema",
            "percent": "5-15"
        },
        {
            "name": "Iritis",
            "percent": "5-15"
        },
        {
            "name": "Corneal endothelial cell loss",
            "percent": "1-5"
        },
        {
            "name": "Blepharitis",
            "percent": "1-5"
        },
        {
            "name": "Eye pain",
            "percent": "1-5"
        },
        {
            "name": "Cystoid macular edema",
            "percent": "1-5"
        },
        {
            "name": "Dry eye",
            "percent": "1-5"
        },
        {
            "name": "Ocular inflammation",
            "percent": "1-5"
        },
        {
            "name": "Posterior capsule opacification",
            "percent": "1-5"
        },
        {
            "name": "Blurred vision",
            "percent": "1-5"
        },
        {
            "name": "Reduced visual acuity",
            "percent": "1-5"
        },
        {
            "name": "Vitreous floaters",
            "percent": "1-5"
        },
        {
            "name": "Foreign body sensation",
            "percent": "1-5"
        },
        {
            "name": "Photophobia",
            "percent": "1-5"
        },
        {
            "name": "Vitreous detachment",
            "percent": "1-5"
        }
    ]
}